STAT+: Who will Vertex buy? How much will it spend? Deal questions dominate its earnings call
Who (or what) is Vertex Pharmaceuticals going to buy?
The question — asked many different ways by analysts — dominated the company’s year-end earnings conference call on Monday evening.
Continue to STAT+ to read the full story…
